Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — 9M 2017 Earnings Presentation

20 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Nov 2, 2017

  1. Slide 1: Conference call Interim report January 1 to September 30, 2017

    Worldwide. On Site. Conference call Interim report January 1 to September 30, 2017 Lübeck, November 2, 2017

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d

  3. Slide 3: Business Highlights 9M Group

    Business Highlights 9M Group  Order intake in Q3 still positive Net Sales (cc), but with reduced dynamic. +7.0% +2.4%  Order intake (currency adjusted): Currency Currency 1,737 adjusted Q3 +2.1% yoy adjusted 9M +4.8% yoy 621 1,704  Strong net sales development in 593 the quarter. YTD still laggin

  4. Slide 4: Order development in 9M Group

    Order development in 9M Group Order entry (€ million) Group Medical Safety Net Sales America 380 +2.0% +3.5% -1.4% +2.4% Africa, Asia, +5.6% +11.9% +3.3% 499 +7.2% Australia Europe 1,050 +4.7% +2.0% +9.0% +2.0% Group 1,928 +4.8% +3.3% +7.6% +2.4% Growth rates are net of currency effects 4

  5. Slide 5: Business development 9M Group

    Business development 9M Group Q3 2016 Q3 2017 Change 9M 2016 9M 2017 Change € million € million % € million € million % Order Intake 628.0 626.3 -0.3 1,849.1 1,928.3 4.3 % growth (FX adjusted) -1.7% 2.1% -0.3% 4.8% Net Sales 592.9 621.0 4.7 1,704.3 1,737.0 1.9 % growth (FX adjusted) -1.1% 7.0% -2.6%

  6. Slide 6: Functional Expenses Group

    Functional Expenses Group 9M 2016 9M 2017 Change Change net of FX and restructuring € million € million % % R&D -163.4 -171.7 5.1 5.5 % of Net Sales -9.6% -9.9% Sales & Marketing -404.4 -412.8 2.1 2.5 % of Net Sales -23.7% -23.8% Administration -150.1 -143.3 -4.5 1.7 % of Net Sales -8.8% -8.2% SG&A

  7. Slide 7: Key Figures Group

    Key Figures Group 9M 2016 9M 2017 Change € million € million % Cashflow from operating activities 90.9 78.5 -13.6 Investments 71.1 63.7 -10.3 1 Cash and cash equivalents 173.9 200.4 15.2 1 Net financial debt 121.0 16.1 -86.7 1 2 0.68 0.07 Net financial debt /EBITDA 1 Capital employed 1,238.7 1,213.7

  8. Slide 8: Business development 9M Segments

    Business development 9M Segments EBIT- Order entry Net sales Net sales EBIT margin Δ in %* € million Δ in %* € million % Europe 4.7 960.7 2.0 42.3 4.4 America 2.0 344.7 2.4 -9.4 -2.7 Africa, Asia, Australia 7.2 431.5 3.3 10.6 2.5 Group 4.8 1,737.0 2.4 43.5 2.5 Medical 3.3 1,106.3 1.6 4.7 0.4 Safety

  9. Slide 9: Outlook Group

    Outlook Group 2016 2017e Net Sales - 1.5 % 0.0 % – 3.0 % (net of currency effects) EBIT margin 5.4 % 5.0 % – 7.0 %* Gross profit margin 45.0 % 44.0 – 46.0 % Dräger Value Added EUR 49.8m EUR 40m – 90m * based on exchange rates at the start of the year 2017 9

  10. Slide 10: Questions & Answers

    Questions & Answers Drager 10 Drager. Technik fiir das Leben®

  11. Slide 11: Appendix

    Appendix Drager

  12. Slide 12: Guidance 2017

    Guidance 2017 2016 Forecast 2017 -1.5% 0.0 - 3.0% Net sales (net of currency effects) (net of currency effects) EBIT margin 5.4% 5.0 - 7.0%1 Dräger Value Added EUR 49.8 million EUR 40 - 90 million Other forecast figures: Gross margin 45.0% 44.0 - 46.0 % Research and development costs EUR 219 million

  13. Slide 13: Business development Segments (Q3)

    Business development Segments Europe Americas Africa, Asia, Australia Dräger Group Q3 2016 Q3 2017 Q3 2016 Q3 2017 Q3 2016 Q3 2017 Q3 2016 Q3 2017 € million € million € million € million € million € million € million € million Order entry 336.7 343.2 134.7 120.4 156.6 162.7 628.0 626.3 Net Sales 325

  14. Slide 14: Business development Segments (9M)

    Business development Segments Europe Americas Africa, Asia, Australia Dräger Group 9M 2016 9M 2017 9M 2016 9M 2017 9M 2016 9M 2017 9M 2016 9M 2017 € million € million € million € million € million € million € million € million Order entry 1,009.9 1,050.0 371.2 379.5 468.0 498.9 1,849.1 1,928.3 Net S

  15. Slide 15: Business development Medical

    Business development Medical Q3 2016 Q3 2017 Change Change 9M 2016 9M 2017 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 417.4 412.4 -1.2 1.4 1,218.1 1,253.4 2.9 3.3 Europe 206.1 210.0 1.9 2.2 614.5 624.7 1.7 2.0 America 96.3 84.0 -12.7 -8.2 256.2 265.

  16. Slide 16: Business development Safety

    Business development Safety Q3 2016 Q3 2017 Change Change 9M 2016 9M 2017 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 210.6 213.9 1.5 3.5 631.0 674.9 7.0 7.6 Europe 130.6 133.2 2.0 3.0 395.4 425.3 7.5 9.0 America 38.4 36.3 -5.2 -1.3 115.0 114.0 -0.9

  17. Slide 17: Cash-flow statement Group

    Cash-flow satement Group 9M 2016 9M 2017 Change € million € million % Group net profit 12.5 24.5 96.4 Change in inventories -59.1 -84.4 -42.9 Change in receivables 133.2 109.2 -18.0 Change in payables -31.0 -10.9 65.0 Depreciation and amortization 61.6 62.4 1.2 Other operating cash flow items -26.4

  18. Slide 18: Earnings per share Group

    Earnings per share Group 2012 2013 2014 2015 2016 Net profit in € thousand 135,680 119,895 104,666 33,288 81,736 Earnings attributable to non‐controlling interests in € thousand 3,319 563 105 287 345 Szenario: 100% distribution: pay‐out ratio 100% 100% 100% 100% 100% Earnings attributable to partici

  19. Slide 19: Financial calendar 2018

    Financial calendar 2018 March 8, 2018 - Annual accounts press conference - Analysts’ meeting April 26, 2018 - Report for the first three months 2018 Conference call May 4, 2018 - Annual shareholders' meeting, Lübeck, Germany July 26, 2018 - Report for the first six months 2018 Conference call Octobe

  20. Slide 20: Contact

    Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88

Drägerwerk AG & Co. KGaA — 9M 2017 Earnings Presentation on 6ix